Free Trial
NYSEARCA:PBE

Invesco Biotechnology & Genome ETF (PBE) Price, Holdings, & News

$70.30 -0.65 (-0.91%)
As of 01:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Key Stats

Today's Range
$70.05
$70.48
50-Day Range
$64.00
$70.99
52-Week Range
$54.52
$72.84
Volume
2,558 shs
Average Volume
8,245 shs
Market Capitalization
$242.54 million
Assets Under Management
$225.79 million
Dividend Yield
0.23%
Net Expense Ratio
0.58%
Aggregate Rating
Moderate Buy

ETF Overview

Invesco Biotechnology & Genome ETF Expenses

TypePBEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.56%0.51%0.53%
Other Expenses0.08%0.47%0.56%0.59%0.56%
Total Expense0.58%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.58%0.60%0.63%0.58%0.60%
Receive PBE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PBE ETF News Headlines

PBE Invesco Biotechnology & Genome ETF
Invesco Dynamic Biotech & Genome ETF (PBE)
Trump’s Plan May Undo 1933’s Biggest Financial Injustice
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.tc pixel
See More Headlines

PBE ETF - Frequently Asked Questions

Invesco Biotechnology & Genome ETF's stock was trading at $66.53 at the beginning of 2025. Since then, PBE shares have increased by 5.8% and is now trading at $70.37.

Top institutional shareholders of Invesco Biotechnology & Genome ETF include Gerber Kawasaki Wealth & Investment Management (7.37%), Bank of America Corp DE (1.69%), YHB Investment Advisors Inc. (0.70%) and Cetera Investment Advisers (0.59%).

Shares of PBE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Biotechnology & Genome ETF investors own include Micron Technology (MU), Pfizer (PFE), Devon Energy (DVN), Intel (INTC), Activision Blizzard (ATVI), NVIDIA (NVDA) and Bristol Myers Squibb (BMY).

Fund Details

Issuer
Invesco
Fund Name
Invesco Biotechnology & Genome ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:PBE
Inception Date
6/23/2005
Fund Manager
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser

Fund Focus

Asset Class
Equity
Benchmark
Dynamic Biotech & Genome Intellidex Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
31

Fund Statistics

Assets Under Management
$225.79 million
Average Daily Volume
$17.04 thousand
Discount/Premium
-0.05%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
1
Put Options
5
Call Options
1
Short Interest
600 shs

Miscellaneous

Beta
0.87
Creation Unit
10,000
Creation Fee
$500.00
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Top 10 PBE Holdings

PBE Sector Exposure

PBE Industry Exposure


This page (NYSEARCA:PBE) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners